Rochester Democrat & Chronicle
Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition. From almost 7,000 applicants, RTI was reviewed and was selected to be among the 113 top entries. RTI will now go to the next phase which is one step away from a top award of $1 million. Click here to read more